The ‘tech prosperity deal’ will see the UK and US co-operate in areas including artificial intelligence, quantum computing and nuclear power.

Nordisk and Eli Lilly are set to reshape the oral GLP-1 market as patient demand grows and new therapies emerge. Learn more ...